Navigation Links
Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
Date:2/14/2011

SAN LEANDRO, Calif., Feb. 14, 2011 /PRNewswire/ -- Mercator MedSystems, Inc., a privately held medical technology company focused on treating drug-resistant hypertension, announced today that Neil P. Desai, Ph.D. was elected to its Board of Directors. Dr. Desai has an extensive background in drug-delivery and global development and holds over 100 patents in the field. Prior to the acquisition of Abraxis Bioscience, Inc. (ABI), by Celgene Corporation in late 2010, he was Senior Vice-President of Global Research and Development for ABI where he was responsible for the development of ABI's proprietary product pipeline and intellectual property portfolio. He is presently Vice-President of Strategic Platforms at Celgene Corporation.

"Dr. Desai's extensive experience in drug development, global clinical research, and commercialization in an entrepreneurial environment is a perfect addition to Mercator's Board as we move to the next development stage of our unique approach to treating drug-resistant hypertension," said Thomas M. Loarie, Executive Chairman of Mercator MedSystems, Inc. Loarie also noted that this came at an ideal time with investor and strategic interest growing in hypertension treatments following the recent acquisition of Ardian, Inc., by Medtronic, Inc.

"I have been working with Mercator for over three years on collaborations using products developed by Abraxis so I have had a front row seat observing the development of their proprietary site-specific drug delivery platform," said Dr. Neil Desai. He added, "It's an exciting time in the evolution of Mercator and I am delighted to become a contributor."

Last year, pre-clinical data were presented on Mercator's therapeutic approach to drug-resistant hypertension and clinical data were presented on Athersys' use of Mercator's technology to deliver stem cells post-myocardial infarction at the 2010 Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.

About Mercator MedSystems, Inc.

Mercator MedSystems, Inc., based in San Leandro, Calif., is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery of therapeutic agents for applications in hypertension, cardiovascular disease, oncology and regenerative medicine.


'/>"/>
SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Relievant Medsystems Announces Completion of $20 Million Financing
2. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
3. Plato BioPharma, Inc Appoints New Board Member
4. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
5. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
6. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
7. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
10. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
11. Sysmex America Appoints Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):